rac Naproxen-d3 is a deuterated form of the active pharmaceutical ingredient naproxen, where three hydrogen atoms in the methyl group are replaced with deuterium. It is used as a research compound in pharmaceutical development and analytical studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 958293-77-1
Alendronic acid-d6
pharmaceutical raw material
Alpha3-(((1,1-Dimethylethyl)amino)methyl)-6-hydroxy-1,3-benzenedimethan-alpha1,alpha1,alpha3-d3-ol
pharmaceutical raw material
Tricyclo[3.3.1.13,7]decan-2,2,8,8,9,9-d6-1-amine
pharmaceutical raw material
(R)-(-)-Phenylephrine-d3 HCl
pharmaceutical raw material
Defluoroofloxacin
pharmaceutical raw material
Sotalol hydrochloride
pharmaceutical raw material
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-6-[3-hydroxy-6-methyl-4-[methyl(trideuterio(113C)methyl)amino]oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
pharmaceutical raw material
Flurazepam Monohydrochloride EP Impurity C
pharmaceutical raw material
3,3,3-trideuterio-2-(6-methoxynaphthalen-2-yl)propanoic acid
CMWTZPSULFXXJA-FIBGUPNXSA-N
[2H]C([2H])([2H])C(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O